1998
From: American Association For The Study of Liver Diseases
Nation's Leading Biomedical Researchers Present Breakthroughs in Liver DiseaseChicago -- The nation's leading biomedical researchers will present breakthrough therapies and technologies in liver disease November 8 through November 10 at the 49th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD), the leading medical organization for liver research. AASLD encourages the media to attend the more than 500 presentations covering liver-related diseases featuring never-before published findings on: - Promising new combination therapies for Hepatitis C & B
- African Americans' dangerously low response rate to Hepatitis C therapies
- The crushing burden of increasing cases of Hepatitis C virus on the U.S. healthcare system
- Advances in gene therapy technologies
A press room will be available for media representatives in the Sheraton Chicago Hotel, Parlor D, on Sunday, November 8, from noon to 5 p.m. and Monday, November 9, through Tuesday, November 10, 9 a.m. to 5 p.m.Further information on the meeting, including news releases and abstract highlight summaries, will be distributed to the media and are also available upon request. AASLD is the leading medical organization for advancing the science and practice of hepatology. Founded by physicians in 1950, AASLD's vision is to prevent and cure liver disease. Today, AASLD provides representation and education for more than 2,200 liver researchers, physicians, and surgeons worldwide.
| |